Status:
TERMINATED
Grand Autohemo-Therapy With Oxygen-ozone on Patients With Hypertonia
Lead Sponsor:
Herrmann Apparatebau GmbH
Conditions:
Hypertonia
Eligibility:
All Genders
45+ years
Brief Summary
The objective of this clinical study is to evaluate the influence of the Great autohemotherapy with oxygen-ozone (hyperbaric ozone therapy ) to describe the cardiovascular system in patients with resi...
Eligibility Criteria
Inclusion
- Resistant Hypertension \> 140 / \> 90mmHg
- Inclusion age : 45 +
- Regular monitoring of blood levels considered
- pre-medication to lower blood pressure for at least 3 weeks before the preliminary investigation consistent
- Men and Women
Exclusion
- derailed diabetes
- renal impairment , renal creatinine clear \<50 ml
- Non - austherapierte cancer / tumor patients
- Non - adjusted thyroid dysfunction
- BMI\> 35
- LVEF \<limit ( " 35% " )
- Peripheral AVK ( ABI - measurement ) \> Stage II
- regurgitation \> Stage I
- abdominal aneurysm
- infections
- acute febrile infections with temperature \> 38.5 ° C
- COPD and asthma to stage III
- dyspnea NYHA \> Stage III
- z.n. Stroke shorter than 12 weeks
- Acute liver failure
- Acute Apoplexy
- Severe poisoning
- drug addiction
- hyperthyroidism
- Hypotension
- hypocalcemia
- hypoglycemia
- ozone allergy
- pregnancy
- clotting problems ( hemophilia )
- pre-existing condition with hemoglobin \< 9mg/dl
- Fresh myocardial infarction
- Internal bleeding
- thrombocytopenia
- Acute alcohol
- Citrus allergy when using sodium citrate
Key Trial Info
Start Date :
August 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2016
Estimated Enrollment :
19 Patients enrolled
Trial Details
Trial ID
NCT01902602
Start Date
August 1 2013
End Date
June 1 2016
Last Update
March 16 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dr. Panos Porikis
Biblis, Hesse, Germany, 68647